|
|
| Drugs
known as entry inhibitors and fusion inhibitors are being developed to
prevent HIV from getting into cells. Entry inhibitors are designed to
block the receptors HIV uses to attach itself to cells. Fusion
inhibitors prevent the virus from fusing with the cell.
Side Effects The most common side effects of fusion inhibitors include injection site redness, swelling, soreness and in some cases patients experience headache, dizziness and in extreme cases a few have reported rash, fever, and vomiting. Fusion Inhibitors have not been approved in Canada to date, however, it is expected that T-20, the first of this class, will be approved for use in Canada by Autumn 2003. |
| Updated July 13, 2004 |
|
|
|
1168 Drouillard Rd., Suite B, Windsor, ON N8Y 2R1 PH: 519-973-0222 or 1-800-265-4858 FAX: 519/973-7389 |